ZYMAR® (gatifloxacin ophthalmic solution) solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
Aerobic Gram-Positive Bacteria:
Aerobic Gram-Negative Bacteria:
* Efficacy for this organism was studied in fewer than 10 infections
DOSAGE AND ADMINISTRATION
The recommended dosage regimen for the treatment of bacterial conjunctivitis is:
Days 1 and 2: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times daily.
Days 3 through 7: Instill one drop up to four times daily while awake.
ZYMAR® (gatifloxacin ophthalmic solution) (gatifloxacin ophthalmic solution) 0.3% is supplied sterile in a white, low density polyethylene (LDPE) bottle with a controlled dropper tip and a tan, high impact polystyrene (HIPS) cap in the following sizes:
2.5 mL in a 6 mL bottle- NDC 0023-9218-03
5 mL in an 10 mL bottle- NDC 0023-9218-05
Note: Store at 15°-25°C (59°-77°F). Protect from freezing.
Revised August 2004 ©2004 Allergan, Inc. Irvine, CA 92612,
U.S.A. Licensed from: Kyorin Pharmaceuticals Co., Ltd. Marks owned by Allergan,
FDA Rev date: 6/20/2005
Last reviewed on RxList: 8/14/2007
This monograph has been modified to include the generic and brand name in many instances.
Additional Zymar Information
Zymar - User Reviews
Zymar User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Find out what women really need.